Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766787 · ClinicalTrials.gov registry record · NA

The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

A NA study of Refractive Ametropia, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
190
Enrollment target
15
Study locations

NCT05766787 is a NA study of Refractive Ametropia that has completed, run by Alcon Research. The registered enrollment target is 190 participants, roughly in line with the 197-participant average among 5 other Refractive Ametropia trials with a reported enrollment target. The trial reports 15 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766787, a NA study of Refractive Ametropia, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
190 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.

Conditions Studied

Interventions

  • DEVICE Senofilcon A contact lenses
  • DEVICE CLEAR CARE
  • DEVICE Serafilcon A contact lenses

Study Locations (15)

Florida

  • Omega Vision Center P.A. - Longwood
  • Kindred Optics at Maitland Vision - Maitland
  • Vision Health Institute - Orlando
  • Tallahassee Eye Center - Tallahassee

California

  • Kurata Eyecare Center - Los Angeles
  • Dr. Elsa Pao, OD - Oakland
  • Pacific Rims Optometry - San Francisco

Minnesota

  • The Eye Doctors Inc - Eden Prairie
  • Complete Eye Care of Medina - Medina

Tennessee

  • Optometry Group, PLLC - Memphis
  • Total Eye Care PA - Memphis

Kansas

  • Heart of America Eye Care - Shawnee Mission

New York

  • SUNY College of Optometry Clinical Vision Research Center - New York

Ohio

  • ProCare Vision Centers, Inc. - Granville

Rhode Island

  • West Bay Eye Associates - Warwick

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2023-03-29
Est. Completion 2023-06-02
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT05766787

The ClinicalTrials.gov registry entry for NCT05766787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 197-participant average among 5 other Refractive Ametropia trials with a reported enrollment target. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Ametropia appearing as the primary indexed condition, and to 3 interventions - of which Senofilcon A contact lenses is the first listed.

NCT05766787 reports 15 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Minnesota.

Frequently Asked Questions

What is clinical trial NCT05766787 about?

NCT05766787 is a clinical study titled "The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses". The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.

What is the current status of trial NCT05766787?

This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2023-03-29. Estimated completion is 2023-06-02.

What conditions does trial NCT05766787 study?

This clinical trial studies the following conditions: Refractive Ametropia.

What interventions are being tested in trial NCT05766787?

The interventions under investigation include: Senofilcon A contact lenses (DEVICE), CLEAR CARE (DEVICE), Serafilcon A contact lenses (DEVICE).

Who is sponsoring clinical trial NCT05766787?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766787 being conducted?

This trial has 15 study locations across California, Florida, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Refractive Ametropia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.